Corporate Presentation
Upcoming Events
European Hematology Association (EHA) 2025 Congress
EHA2025 Congress abstracts may be accessed online via the EHA Library.
EHA Poster Presentations
Friday, June 13, 2025, Time 18:30 to 19:30 CEST
Abstract #: PF511
Title: Efficacy and Safety of Olutasidenib Monotherapy in Primary Refractory AML: A Post Hoc Analysis of a Phase 2 Study
Presenter: Antonio Curti, M.D., Ph.D.
Abstract #: PF516
Title: Effect of Mutation Type and Co-mutations on Response to Olutasidenib in Patients With R/R Mutated IDH1 AML
Presenter: Stéphane de Botton, M.D., Ph.D.
Abstract #: PF530
Title: Olutasidenib as Maintenance Therapy after Treatment Response in Mutated IDH1 Acute Myeloid Leukemia
Presenter: Andrew H. Wei, MBBS, Ph.D.